Ángel Cequier

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Bivalirudin for Patients with Acute Coronary Syndromes

Gregg W. Stone, Brent McLaurin, David A. Cox et al. · New England Journal of Medicine · 2006 · 1.4K citations · Full text

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

Pierluigi Tricoci, Zhen Huang, Claes Held et al. · New England Journal of Medicine · 2011 · 747 citations · Full text

Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction

Gilles Montalescot, Arnoud W.J. van ‘t Hof, Frédéric Lapostolle et al. · New England Journal of Medicine · 2014 · 638 citations · Full text